Inhibikase Therapeutics Inc (IKT) — Free Cash Flow Generation Index
Latest as of September 2020:
1.00x
Inhibikase Therapeutics Inc (IKT) has a Free Cash Flow Generation Index of 1.00x as of September 2020. Free cash flow of $75.52K represents 1% of operating cash flow ($75.52K). Read Inhibikase Therapeutics Inc total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$75.52K
USD
Operating Cash Flow
$75.52K
USD
Capital Expenditures
$0.00
USD
Inhibikase Therapeutics Inc Free Cash Flow Generation Index (2018–2018)
Historical FCF Generation Index trend for Inhibikase Therapeutics Inc across 1 annual periods.
Annual Free Cash Flow Generation for Inhibikase Therapeutics Inc (2018–2018)
Year-by-year Free Cash Flow Generation Index for Inhibikase Therapeutics Inc. For the full company profile including market capitalisation, see IKT market cap overview.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2018 | 1.00x | $714.99K | $714.99K | $0.00 | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).